PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
+0.2%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$645M
AUM Growth
-$124M
(-16%)
Cap. Flow
-$61.9M
Cap. Flow
% of AUM
-9.6%
Top 10 Holdings %
Top 10 Hldgs %
76.62%
Holding
47
New
2
Increased
6
Reduced
10
Closed
4
Top Buys
1 |
NovoCure
NVCR
|
+$6.58M |
2 |
PTC Therapeutics
PTCT
|
+$5.5M |
3 |
Acadia Pharmaceuticals
ACAD
|
+$4.12M |
4 |
BCYC
Bicycle Therapeutics
BCYC
|
+$2.65M |
5 |
Pyxis Oncology
PYXS
|
+$1.35M |
Top Sells
1 |
Insmed
INSM
|
+$23.3M |
2 |
STAAR Surgical
STAA
|
+$14.4M |
3 |
United Therapeutics
UTHR
|
+$9.71M |
4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$8.37M |
5 |
SAGE
Sage Therapeutics
SAGE
|
+$7.3M |
Sector Composition
1 | Healthcare | 97.26% |
2 | Financials | 2.74% |